These data support the application to the U.S. Food and Drug Administration seeking approval of a subcutaneous induction dosing regimen for SKYRIZI for patients with moderately to severely active ...
Learn how to lower your fall risk with rheumatoid arthritis, including causes, assessments, and practical steps from doctors and therapists to improve safety and mobility.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results